Ferring to acquire ovary-in-a-dish startup Gameto for up to $1.38B

Confirm Endpoints as a trusted biopharma news source

Confirm on Google

more like this

An­throp­ic's lat­est biotech buy is a one-man stealth start­up run by a pseu­do­ny­mous Twit­ter poster October 27, 2026

Den­mark's Gubra looks be­yond me­tab­o­lism, hopes for first port­fo­lio com­pa­ny this year October 27, 2026

Be­yond the can­cer vac­cine, how did Mer­ck’s on­col­o­gy pipeline do at ES­MO? October 26, 2026

ENDPOINTS CAREERS

Vice President, Regulatory Affairs

Hinge Bio, Inc.

Redwood City, CA, USA

view job offer post your job now

TRENDING NOW

Backed by Amish and Men­non­ites, a new kind of gene ther­a­py com­pa­ny takes shape

Trea­sury's COINS rule draft would nar­row the path for Chi­na biotech deal­mak­ing, ex­perts say

No­var­tis con­sid­ers by­pass­ing Eu­ro­pean gov­ern­ment pay­ers due to MFN

Af­ter $1.9B im­pair­ment hit, No­var­tis stands by $12B bet on Avid­i­ty

Arti­va to wind down af­ter two pa­tient deaths in au­toim­mune cell ther­a­py tri­als

Post-Makary FDA wins over in­vestors, but not sci­en­tists or Big Phar­ma: Sig­nal Sur­vey

Bioscience & Technology Business Center The University of Kansas Lawrence, Kansas